Hemogenyx Pharmaceuticals Plc reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was GBP 4.32 million compared to GBP 1.13 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.434 GBX | -2.78% | -2.78% | -37.65% |
04-25 | EARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payout | AN |
04-25 | Hemogenyx Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-37.65% | 25.18M | |
+15.55% | 118B | |
+12.66% | 106B | |
-2.53% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.92% | 15.56B | |
+6.19% | 13.63B | |
+28.83% | 12.27B |
- Stock Market
- Equities
- SILF Stock
- News Hemogenyx Pharmaceuticals Plc
- Hemogenyx Pharmaceuticals Plc Reports Earnings Results for the Half Year Ended June 30, 2023